Optimising laboratory operations for human genetics diagnosis with Technology Transfer

What is technology transfer?

Technology transfer is the process of transferring knowledge, skills, technologies, and processes from one organisation to another. In the context of genetic testing laboratories, technology transfer involves the implementation of innovative technologies and protocols to improve efficiency, accuracy, and quality. By adopting technology transfer, laboratories can streamline their own workflows using proprietary technologies, optimise their costs, and provide more comprehensive genetic services to their patients.

Benefits of technology transfer for genetic laboratories

Despite the rapid advancements in genetic testing technologies, laboratories often encounter several persistent challenges when it comes to outsourcing genetic testing. Technology transfer can offer in-house solutions to every laboratory, unlocking its full potential by:

1. Enhancing a laboratory’s portfolio: Technology transfer can offer several solutions for genetic testing based on the laboratory’s needs and the patient base they serve.
2. Minimise turnaround time (TAT): Longer turnaround times are usually a burden for laboratories that send out samples for genetic testing services and are often the main reason for patient dissatisfaction. Technology transfer reduces the TAT to the minimum and could be considered a competitive advantage for the laboratory.
3. Monitoring cost and budget: Technology transfer helps consolidate all needed resources, enabling cost-effective operations and full control of the laboratory’s budget.
4. Data monitoring and analysis: Managing and analysing large volumes of genetic data can be challenging, particularly when using outdated or incompatible software systems. Technology transfer could introduce integrated software platforms that enhance data management, analysis, and interpretation.
5. Brand awareness: Using a verified and well-known technology transfer platform in-house could increase the laboratory’s visibility in the market, resulting in a potential increase in the market share.

What should laboratory directors and laboratory owners look for when introducing a technology transfer platform

When considering the introduction or integration of a technology transfer platform into their operations, laboratory directors and owners should carefully evaluate several critical factors to ensure successful implementation and optimal performance:

1. Laboratory’s portfolio: Evaluate the laboratory’s portfolio and needs. The chosen platform should enhance its portfolio of tests by offering various assays.
2. Compatibility: Ensure the chosen platform is compatible with the laboratory’s current equipment, software, and workflows. Seamless integration is essential to avoid disruptions and ensure smooth transitions.
3. Scalability: Select a platform that can grow with the laboratory’s needs. It should offer scalable solutions that can handle increasing volumes of tests and accommodate future expansion without requiring significant overhauls.
4. Comprehensive support and training: Ensure that the provider offers extensive support, including initial deployment, training for laboratory personnel, and ongoing technical assistance. A well-supported platform reduces downtime and enhances user proficiency.
5. Regulatory compliance: Confirm that the platform complies with relevant regulatory standards and guidelines. This ensures that the laboratory meets all legal and quality requirements, and is particularly important for laboratories operating in multiple regions with varying regulations.
6. User-friendly interface: Study the platform interface. A platform with an intuitive, user-friendly interface can significantly reduce the learning curve and improve productivity. It should provide clear, straightforward protocols that staff can easily follow.
7. Cost-effectiveness: Consider the total cost of ownership, including initial investment, maintenance, and operational costs. A cost-effective platform provides value by optimising resources and reducing unnecessary expenses.
8. Data security and privacy: Ensure the platform offers robust data security measures to protect patient information and comply with privacy regulations. This is especially important given the sensitive nature of genetic data.
9. Customisation and flexibility: Look at the customisation options on offer. Laboratories have unique needs and workflows, so the platform should have the ability to tailor the system to specific requirements, such as different levels of automation. Flexibility in the platform allows for adjustments as the laboratory’s needs evolve.
10. Future-proofing: Check that the chosen platform is adaptable to future developments due to new technological advancements and laboratory suggestions.

Medicover Genetics Technology Transfer Platform

Medicover Genetics’ Technology Transfer Platform is designed to facilitate the integration of multiple assays, such as (NIPT) with (PGT) and oncology, into a single sequencing run. The use of proprietary technology, bioinformatics, and validated protocols, empowers laboratories to set up and deploy high-fidelity in-house genetic services and optimise their operations. The platform combines the company’s VERACITY and VERACITY High Content (HC) NIPT kits with TarCET kits, providing a comprehensive solution for genetic testing. All kits are NGS-based and CE-marked.

VERACITY and VERACITY High Content (HC) kits are automatable kits for NIPT, with reagents for up to 96 reactions. VERACITY kit tests for autosomal aneuploidies, sex chromosome aneuploidies, microdeletions, and the presence of the Y chromosome. VERACITY HC additionally targets over 2,000 variants related to 100 autosomal recessive and X-linked monogenic diseases.

TarCET kits are multigene kits for the identification of variants associated with genetic disorders, each containing reagents for 16 reactions. TarCET kits cover multiple disciplines: reproductive health, PGT, neonatal, postnatal, and oncology.

Key advantages of Medicover Genetics’ Technology Transfer Platform for genetic testing

1. Improved efficiency: Medicover Genetics’ Technology Transfer Platform enables laboratories to consolidate multiple assays into a single sequencing run, reducing hands-on processing time and cost and increasing sample handling efficiency.
2. Enhanced accuracy: Medicover Genetics’ proprietary technology, bioinformatics, and validated, user-friendly protocols ensure that laboratory personnel follow standardised procedures, minimising the likelihood of human error and improving the quality of results.
3. Cost optimisation: By consolidating workflows and minimising re-runs, laboratories can reduce operational costs and optimise their resource allocation.
4. Scalability: Small kit sizes allow scalable solutions for laboratories of any size to expand their genetic testing capabilities, meeting the growing demand for personalised medicine.
5. Comprehensive testing: Integrated platforms offer a wide range of genetic tests, including NIPT, oncology, postnatal, reproductive health, neonatal, and PGT, in a single sequencing run.
6. Integrated software and platform: The platform integrates with Medicover Genetics’ TarCET IVD kits, allowing laboratories to expand their genetic testing capabilities beyond NIPT and offer a more comprehensive range of tests to healthcare providers, associates, and patients.
7. Minimising human error: Medicover Genetics’ detailed and user-friendly protocols, along with various workflow checkpoints, minimise human error and ensure consistent quality.

Support and deployment

Medicover Genetics offers ongoing support to all Technology Transfer partners, including:

1. Deployment program: A well-designed deployment program and structured multi-faceted operational support team ensure smooth implementation.
2. Ongoing support: Assistance in troubleshooting, quality and performance monitoring, marketing and commercialisation insights, and technical support offers partners continued peace of mind.
3. Automated software updates: Automatic software updates ensure seamless operations.

Conclusion

In the rapidly evolving field of human genetics diagnostics, technology transfer is a powerful tool for optimising laboratory operations. By leveraging innovative technologies and protocols, laboratories can improve efficiency, accuracy, and quality while reducing costs. Medicover Genetics’ Technology Transfer Platform is a prime example of this process, offering a comprehensive solution for genetic testing that can help laboratories optimise their operations and provide high-quality results to their patients.